Depressive disorders are the greatest contributors to the burden of disease among all psychological disorders (
1). Due to the increasing recognition of deleterious impact of depression on psychosocial functioning and quality of life, screening for depression is increasingly common outside the mental health treatment centers in areas such as primary care clinics and schools (
2). Concurrently, there is a growing emphasis on psychological and psychiatric interventions that are informed by outcome monitoring (
3-
5). Both of these trends underscore the need for depression self-report scales that are brief to administer, comprehensive in content, and psychometrically valid. Numerous such scales are developed in recent decades.
Among the most widely used and well-validated self-report measures of depression is the patient health questionnaire (PHQ) (
6). The scale contains nine items assessing DSM-IV (diagnostic and statistical manual of mental disorders, fourth edition) major depressive disorder (MDD) symptoms in the last week, which is scored based on a four-option Likert scale from 0 (not at all) to 3 (nearly every day). The scale is subjected to extensive psychometric validation (
7) and nearly cited 9000 times. Since its publication, the PHQ-9 is successfully translated into dozens of languages and these foreign language versions of the scale had good validity and reliability compared with the original English language scale (
8).
Iran is a country with a great need for well-validated assessments of depression. With a population of over 82 million people, Iran is the 18th most populous country in the world (
9). A recent review of the extant literature regarding the prevalence of MDD in Iran by Sadeghirad et al., estimated that the prevalence of MDD in the past year was 4.1%, which corresponds to an estimated 3.3 million Iranians. These findings were based on 24 studies that used a combination of well-validated self-report scales and clinician-administered diagnostic interviews to assess MDD symptoms in 49273 Iranians. Also, results of the Iranian mental health survey showed that the prevalence of depression based on score 2 and higher in the general health questionnaire (GHQ)-28 was 10.39% (
10). Impacts of the earthquake on mental health are a concern among survivors of disasters. Depression is one of the major mental health outcomes after natural disasters. The prevalence of depression after earthquakes was reported 9% to 79% (
11-
15). In a study on survivors of an earthquake in Pakistan in 2005, the prevalence of depression was 70.9% six months after the disaster (
16). Notably, female gender was a major risk factor for MDD across studies, with females being nearly twice as likely to have MDD as males (
17).
The authors are aware of only four studies examining a Persian (Farsi) translation of the PHQ-9 to assess depression symptoms in Iranian subjects. In the first study, Khamseh et al. translated the PHQ-9 into Persian and administered it to 185 patients receiving treatment for diabetes. This version of the scale demonstrated strong reliability (Cronbach’s alpha = 0.86). A clinical cut off score of 13 was established for the measure and 46% of patients in this sample exceeded the cut off. The authors noted that the rate of depression observed in the sample was unusually high compared with the general population of Iran, but noted that it was consistent with high rates of depression symptoms in individuals with diabetes (
18). In the second study, 1006 patients receiving treatment in healthcare centers were screened for depression (
19). The results suggested strong validity and reliability of the Persian measure of the PHQ-9 and indicated that although 77% of the screened subjects had at least some depression symptoms, moderately severe and severe cases were quite rare (7%). Third, a pilot study evaluated the Persian version of the PHQ-9 in 20 patients seeking medical treatment for asthma and adequate psychometric properties were found for the scale (
20). The fourth study found adequate psychometric properties of a brief version of the PHQ (PHQ-4) in patients with chronic obstructive pulmonary disease (
21).
Although these studies suggested that the Persian version of the PHQ-9 may be a valid tool to assess depression symptoms among Iranian subjects, they are limited by their reliance on a mostly urban population of individuals receiving medical treatment. In addition, the studies primarily aimed at determining the prevalence of MDD rather than validating the scale. Therefore, factor structure of the scale is not investigated yet.